Intech Investment Management LLC Has $1.10 Million Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Intech Investment Management LLC lifted its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 61.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,544 shares of the company’s stock after purchasing an additional 6,316 shares during the quarter. Intech Investment Management LLC’s holdings in Ryan Specialty were worth $1,098,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Hollencrest Capital Management bought a new stake in Ryan Specialty during the third quarter worth approximately $25,000. Assetmark Inc. bought a new stake in shares of Ryan Specialty during the 3rd quarter worth $34,000. GAMMA Investing LLC grew its stake in Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after buying an additional 297 shares during the last quarter. Crewe Advisors LLC bought a new position in Ryan Specialty in the 2nd quarter worth $39,000. Finally, Rothschild Investment LLC acquired a new position in Ryan Specialty during the 2nd quarter worth $87,000. Institutional investors own 84.82% of the company’s stock.

Insider Buying and Selling at Ryan Specialty

In related news, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the completion of the sale, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at $884,236.54. This trade represents a 54.42 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director David P. Bolger sold 7,055 shares of the business’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the transaction, the director now directly owns 78,149 shares in the company, valued at approximately $5,539,201.12. This represents a 8.28 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Ryan Specialty Price Performance

NYSE:RYAN opened at $75.10 on Thursday. The company has a market capitalization of $19.66 billion, a price-to-earnings ratio of 97.74, a PEG ratio of 1.69 and a beta of 0.62. The company has a 50-day moving average of $69.50 and a 200-day moving average of $62.95. Ryan Specialty Holdings, Inc. has a 52 week low of $41.49 and a 52 week high of $75.86. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. During the same period in the previous year, the business earned $0.32 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. As a group, equities research analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were paid a dividend of $0.11 per share. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 annualized dividend and a yield of 0.59%. Ryan Specialty’s dividend payout ratio is currently 57.14%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on RYAN. Bank of America raised their price target on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. The Goldman Sachs Group upped their price target on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a report on Wednesday, October 9th. Barclays raised their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their target price for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. Finally, JPMorgan Chase & Co. raised their price target on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $71.67.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.